{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/dyspepsia-pregnancy-associated/prescribing-information/antacids-alginates/","result":{"pageContext":{"chapter":{"id":"891c5a5d-fe64-5740-8bea-1288bb40fe1d","slug":"antacids-alginates","fullItemName":"Antacids and alginates","depth":2,"htmlHeader":"<!-- begin field 55874ba9-8066-416e-891f-4fee56c9da77 --><h2>Antacids and alginates</h2><!-- end field 55874ba9-8066-416e-891f-4fee56c9da77 -->","summary":"","htmlStringContent":"<!-- begin item 4848be33-8e1b-4f64-9a87-7ee3ad49501c --><!-- end item 4848be33-8e1b-4f64-9a87-7ee3ad49501c -->","topic":{"id":"b8d88ee2-8a69-52eb-9d32-912284197e1f","topicId":"dc0be124-58d0-4024-933f-b2fbd474ded2","topicName":"Dyspepsia - pregnancy-associated","slug":"dyspepsia-pregnancy-associated","lastRevised":"Last revised in April 2017","chapters":[{"id":"60f9996f-609e-58ab-a9f8-6c7592ee178e","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"c2b3abe4-1e96-5b8c-b8d3-09d2cb373103","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"a73c5a28-6104-52d9-800f-46667f547593","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"47b7f91b-c83d-54ef-8574-e76eb372bd2f","slug":"changes","fullItemName":"Changes"},{"id":"4f2d76ee-05fa-5ad6-9f05-94ce8aeea75c","slug":"update","fullItemName":"Update"}]},{"id":"e3b58cd1-dacb-5e2b-83a8-3f22adb3d45e","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"1f0a7f78-310a-5b31-bfaf-767b6e748abc","slug":"goals","fullItemName":"Goals"},{"id":"9c124ebe-f349-5be6-aceb-708911d511ab","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"8fa88023-a3f6-51d6-9cf0-8e6cafd2a378","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"8bc89572-4ae3-55e9-a17a-dcdf07479f7e","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"1b45fcb4-c387-513f-85da-a5f4d0d06c44","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"45c50037-8ca1-55b5-a6aa-9fda720d7647","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"ee1aafc3-d046-5f55-8326-4f6eea576ad4","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"a33a561f-20e2-5055-93ea-13e7f9792241","slug":"definition","fullItemName":"Definition"},{"id":"c0a56bee-ebd7-515f-ad7a-e659b803ef4f","slug":"causes","fullItemName":"Causes"},{"id":"43050203-854e-501c-969a-4ef9ca2e693a","slug":"prevalence","fullItemName":"Prevalence"},{"id":"d37ff081-b4e8-5bed-8525-97babc845cc3","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"1e7d1d6b-e749-549b-80e1-505aeae8c3b0","slug":"complications","fullItemName":"Complications"},{"id":"e925ce1f-978f-5f2d-95c4-42e4c5329ba9","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"5b93254f-d6b2-548f-8332-981acee23d8d","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"37e18679-14e0-55e8-9ff3-98ec1f8b4dc8","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"9df83943-7b99-5528-b96d-cf1a3d31e340","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"4d3fcf99-02c1-5ae0-a88f-6ede4299e2e4","fullItemName":"Management","slug":"management","subChapters":[{"id":"7d3d9638-da7b-5e7c-bee8-d2cddbe706f0","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"b7e38fc5-888d-5f8f-b554-d5a6d7c0169e","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"891c5a5d-fe64-5740-8bea-1288bb40fe1d","slug":"antacids-alginates","fullItemName":"Antacids and alginates"},{"id":"60de1b71-33b9-5a85-8db2-22f04ab2568c","slug":"ranitidine","fullItemName":"Ranitidine"},{"id":"a4e035b2-17fe-5771-bf7c-e6316042dfea","slug":"omeprazole","fullItemName":"Omeprazole"}]},{"id":"dd43a335-6bef-54d0-b721-23c0399cbca6","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"1b228dcd-0e8b-5fbb-8dd4-a3307cb52b3d","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"436e8102-5b89-580c-8c58-6895cda4ae97","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"178fa7df-fb25-5bda-bd69-1cebda0cbbf0","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"09c54592-0d38-52dc-b0b8-33b5dea6130e","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"ad6eb72f-398b-5f96-bd8d-c07cdd9bd570","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"56db1aa0-6292-5b08-9b08-7addf535756d","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"f687e796-c2d6-5737-86fe-8977f4ba5257","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"b7e38fc5-888d-5f8f-b554-d5a6d7c0169e","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"c73bad00-b283-511f-b270-176480eb6330","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field a70e6dc6-c182-44db-b083-a73d010b5480 --><h3>What contraindications and cautions are associated with antacids and alginates?</h3><!-- end field a70e6dc6-c182-44db-b083-a73d010b5480 -->","summary":"","htmlStringContent":"<!-- begin item f2d7e1fe-d2eb-432e-ae5e-a73d010b5512 --><!-- begin field bb325377-0775-405e-95f2-a73d010b5480 --><ul><li>Avoid antacid or alginate products if the person is known to be hypersensitive to any of the ingredients or excipients. </li><li>For people with hepatic impairment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dyspepsia-pregnancy-associated/references/\">BNF 72, 2016</a>]:<ul><li>Avoid antacids containing large amounts of sodium if the person has fluid retention.</li><li>Avoid antacids that cause constipation (can cause coma).</li></ul></li><li>For people with renal impairment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dyspepsia-pregnancy-associated/references/\">BNF 72, 2016</a>]:<ul><li>Avoid antacids containing large amounts of sodium if the person has fluid retention.</li><li>Avoid, or use a lower dose of, antacids containing magnesium salts due to an increased risk of toxicity.</li><li>Aluminium accumulation and toxicity is a risk.</li></ul></li><li>Antacids or other agents that lower gastric acidity should be used carefully in pregnant patients with evidence of iron deficiency because the normal absorption of iron is enhanced by gastric acidity [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dyspepsia-pregnancy-associated/references/\">Ali and Egan, 2007</a>].<strong> </strong></li></ul><!-- end field bb325377-0775-405e-95f2-a73d010b5480 --><!-- end item f2d7e1fe-d2eb-432e-ae5e-a73d010b5512 -->","subChapters":[]},{"id":"03955cfb-4c1d-585a-bd28-f2d208386599","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field 7016e8c8-3dd7-4fb4-9496-a73d010b6de9 --><h3>What adverse effects are associated with antacids and alginates?</h3><!-- end field 7016e8c8-3dd7-4fb4-9496-a73d010b6de9 -->","summary":"","htmlStringContent":"<!-- begin item c3f25837-df8e-4109-98f0-a73d010b6dec --><!-- begin field ec994215-46ea-4fd8-9ebf-a73d010b6de9 --><ul><li id=\"PHP277\">Magnesium-containing antacids may have a laxative effect. </li><li>Aluminium-containing antacids may have a constipating effect.<ul><li>Use of an antacid containing both magnesium and aluminium can reduce these effects.</li></ul></li><li>Calcium-containing antacids can cause rebound acid secretion, hypercalcaemia and alkalosis, and milk-alkali syndrome at prolonged high doses.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/dyspepsia-pregnancy-associated/references/\">BNF 72, 2016</a>]</p><!-- end field ec994215-46ea-4fd8-9ebf-a73d010b6de9 --><!-- end item c3f25837-df8e-4109-98f0-a73d010b6dec -->","subChapters":[]},{"id":"61185df0-9ec4-5645-a40f-571d01d31947","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field 0e0a3886-98fe-4837-97e3-a73d010b89a9 --><h3>What are the drug interactions with antacids and alginates?</h3><!-- end field 0e0a3886-98fe-4837-97e3-a73d010b89a9 -->","summary":"","htmlStringContent":"<!-- begin item ce4d0a5f-294b-46bc-81e7-a73d010b8974 --><!-- begin field 370ce56d-9a8c-4984-9ca2-a73d010b89a9 --><ul><li>Antacids affect the absorption of many drugs and may damage enteric coatings, so ideally should not be taken at the same time [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dyspepsia-pregnancy-associated/references/\">BNF 72, 2016</a>].</li></ul><!-- end field 370ce56d-9a8c-4984-9ca2-a73d010b89a9 --><!-- end item ce4d0a5f-294b-46bc-81e7-a73d010b8974 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}